CORPORATE RENAISSANCE GROUP INC
DEF 14A, 1997-01-22
Previous: GREEN TREE FINANCIAL CORP, S-3/A, 1997-01-22
Next: PAINEWEBBER INVESTMENT TRUST II, DEFS14A, 1997-01-22




                           PROXY STATEMENT PURSUANT TO
              SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934

Filed by the Registrant (BOX CHECKED)

Filed by a Party other than the Registrant (BOX NOT CHECKED)

Check the appropriate box:
(BOX NOT CHECKED)   Preliminary Proxy Statement
(BOX NOT CHECKED)   Confidential,  for Use of the Commission Only (as  permitted
                    by Rule 14a-6(e)(2))
(BOX CHECKED)       Definitive Proxy Statement
(BOX NOT CHECKED)   Definitive Additional Materials
(BOX   NOT   CHECKED)    Soliciting  Material  Pursuant  to   240.14a-11(c)   or
240.14a-12

                        CORPORATE RENAISSANCE GROUP, INC.
                   __________________________________________
                (Name of Registrant as Specified In Its Charter)
                                        
                                        
                                 Not Applicable
                   __________________________________________
     (Name of Person(s) Filing Proxy Statement if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

(BOX CHECKED)       No fee required.

(BOX NOT CHECKED)   Fee computed on table below per Exchange Act Rules
                    14a-6(i)(1) and 0-11.

     1)   Title of each class of securities to which transaction applies:
     2)   Aggregate number of securities to which transaction applies:
          3)    Per unit price or other underlying value of transaction computed
          pursuant to Exchange Act Rule 0-11 (Set forth the amount on which  the
          filing fee is calculated and state how it was determined):
     4)   Proposed maximum aggregate value of transaction:
     5)   Total fee paid:

(BOX NOT CHECKED)   Fee paid previously with preliminary materials.

(BOX NOT CHECKED)   Check  box  if any part of the fee is offset as provided  by
                    Exchange  Act  Rule 0-11(a)(2) and identify the  filing  for
                    which the offsetting fee was paid previously.  Identify  the
                    previous  filing by registration statement  number,  or  the
                    Form or Schedule and the date of its filing.

     1)   Amount Previously Paid:
     2)   Form, Schedule or Registration Statement No.:
     3)   Filing Party:
     4)   Date Filed:


<PAGE>

                        CORPORATE RENAISSANCE GROUP, INC.
                     1185 Avenue of the Americas, 18th Floor
                            New York, New York  10036
                                        
                            NOTICE OF ANNUAL MEETING
                          To Be Held February 19, 1997



To all Stockholders of
CORPORATE RENAISSANCE GROUP, INC.

     NOTICE IS HEREBY GIVEN that the Annual Meeting of Stockholders of CORPORATE
RENAISSANCE GROUP, INC., a Delaware corporation (the "Company"), will be held at
the offices of M.D. Sass, 1185 Avenue of the Americas, 18th Floor, New York, New
York, on Wednesday, February 19, 1997 at the hour of 9:30 A.M. for the following
purposes:

     1.   To elect eight Directors of the Company for the ensuing year.

      2.   To consider and vote upon a proposal to ratify the selection of Ernst
&  Young  LLP  as  independent  auditors for the Company's  fiscal  year  ending
September 30, 1997.

      3.    To  transact  such other business as may properly  come  before  the
meeting.

       All   stockholders  are  cordially  invited  to  attend;  however,   only
stockholders of record at the close of business on January 15, 1997 are entitled
to vote at such meeting or any adjournment thereof.

                                  MARTIN E. WINTER
                                  Secretary
New York, New York
January 22, 1997


WHETHER OR NOT YOU PLAN TO ATTEND THE MEETING, PLEASE SIGN AND DATE THE ENCLOSED
PROXY,  WHICH IS SOLICITED BY THE BOARD OF DIRECTORS OF THE COMPANY, AND  RETURN
IT  TO THE COMPANY IN THE PRE-ADDRESSED ENVELOPE PROVIDED FOR THAT PURPOSE.  ANY
STOCKHOLDER  MAY  REVOKE  HIS PROXY AT ANY TIME BEFORE THE  MEETING  BY  WRITTEN
NOTICE  TO SUCH EFFECT, BY SUBMITTING A SUBSEQUENTLY DATED PROXY OR BY ATTENDING
THE MEETING AND VOTING IN PERSON.

<PAGE>


                        CORPORATE RENAISSANCE GROUP, INC.
                     1185 Avenue of the Americas, 18th Floor
                            New York, New York  10036
                                        
                                        
                                 PROXY STATEMENT


    The Board of Directors presents this Proxy Statement to all stockholders and
solicits their proxies for the Annual Meeting of Stockholders (the "Meeting") of
Corporate  Renaissance  Group, Inc. (the "Company") to  be  held  on  Wednesday,
February 19, 1997.

     All  proxies  duly  executed and received will  be  voted  on  all  matters
presented  at  the Meeting in accordance with the specifications  made  in  such
proxies.  In the absence of specified instructions, proxies so received will  be
voted  (1)  FOR each of the named nominees to the Company's Board of  Directors,
and  (2)  FOR the proposal to ratify the selection of Ernst & Young LLP  as  the
Company's  independent auditors for the fiscal year ending September  30,  1997.
The  Board  does  not know of any other matters that may be brought  before  the
Meeting  nor  does it foresee or have reason to believe that proxy holders  will
have  to vote for substitute or alternate nominees.  In the event that any other
matter  should  come  before the Meeting or any nominee  is  not  available  for
election,  the  persons  named  in the enclosed Proxy  will  have  discretionary
authority  to vote all proxies not marked to the contrary with respect  to  such
matters in accordance with their best judgment.  A proxy may be revoked  at  any
time before being voted by written notice to such effect received by the Company
at  the  address  set forth above, attention:  Martin E. Winter,  Secretary,  by
delivery  of  a  subsequently dated proxy or by a vote cast  in  person  at  the
Meeting.   The Company will pay the entire expense of soliciting proxies,  which
solicitation  will be by use of the mails.  It is anticipated that  these  proxy
materials will be mailed to stockholders of the Company on or about January  22,
1997.

     The total number of shares of Common Stock of the Company outstanding as of
January  15, 1997 (the "Record Date") was 940,350 shares.  The Common  Stock  is
the  only  class of securities of the Company entitled to vote,  each  share  of
Common Stock being entitled to one noncumulative vote.  A majority of the shares
of  Common  Stock  outstanding and entitled to vote as of the  Record  Date,  or
470,176 shares, must be present at the Meeting in person or by proxy in order to
constitute a quorum for the transaction of business.  The affirmative vote of  a
plurality  of  the shares of Common Stock present and entitled to  vote  at  the
Meeting  is required for the election of directors.  The affirmative vote  of  a
majority  of  the shares of Common Stock present and entitled  to  vote  at  the
Meeting is required to pass upon the proposal to ratify the selection of Ernst &
Young  LLP  as independent auditors for the Company.  Pursuant to Delaware  law,
abstentions  and  broker  non-votes  are counted  as  present  for  purposes  of
determining  the  presence  of a quorum.  However, abstentions  are  treated  as
present  and  entitled to vote, and thus have the effect of  a  vote  against  a
matter.   A  broker non-vote on a matter is considered not entitled to  vote  on
that matter, and thus is not considered when counting votes cast on the matter.

     A list of stockholders entitled to vote at the Meeting will be available at
the  Company's offices, 1185 Avenue of the Americas, 18th Floor, New  York,  New
York   10036,  for a period of ten days prior to the Meeting and at the  Meeting
itself for examination by any stockholder.

<PAGE>

                 SECURITY OWNERSHIP OF CERTAIN
                BENEFICIAL OWNERS AND MANAGEMENT


     The  following table sets forth certain information regarding the Company's
Common  Stock beneficially owned as of the Record Date by (i) each person  known
by  the  Company  to own beneficially or exercise voting or dispositive  control
over  5%  or  more of the Company's Common Stock, (ii) each of the nominees  for
director  of the Company, (iii) the Company's Chief Executive Officer, and  (iv)
all executive officers and Directors of the Company as a group:


                            Amount and
Name and Address            Nature
of Beneficial Stockholder   of Beneficial     Percentage of
or Identity of Group(1)     Ownership         Common Stock


Executive Officers and Directors:
Martin D. Sass               71,300                    7.6
Hugh R. Lamle                48,600                    5.2
James B. Rubin                  -0-                    -0-
Thomas M. Garvin                -0-                    -0-
Lawrence W. Leighton          1,000                    *
Edward Lowenthal              3,000                    *
Daniel R. Mazziota              200                    *
Guy E. Waldvogel                -0-                    -0-
All executive officers and directors as a
  group (nine persons)   124,300(2)                   13.2

5% or Greater Shareholders:
Curators Partners, L.P.69,634(3)(4)                    7.4
420 Lexington Avenue
New York, New York

Millenium Trading Co.     48,850(3)                    5.2
111 Broadway
20th Floor
New York, New York  10006

Robert Schneider      52,945 (3)(5)                    5.6
2 Broadway
New York, New York  10004

_______________________
*  Less than one percent

(1)  Unless otherwise indicated, the address of each beneficial owner is c/o the
Company, 1185 Avenue of the Americas, 18th Floor, New York, New York  10036.

(2)  Includes 200 shares of Common Stock held by Martin E. Winter, the Company's
Secretary-Treasurer.

(3)   Based  on a Schedule 13D filed with the Securities and Exchange Commission
(the "SEC").

(4)  Includes 45,000 shares of Common Stock held by certain accounts managed  by
Curators Capital Management, Inc., an affiliate of Curators Partners, L.P.

(5)   Includes 12,000 shares of Common Stock owned jointly with Mr.  Schneider's
spouse.  Excludes 18,650 shares of Common Stock owned by Mr. Schneider's  spouse
over  which Mr. Schneider disclaims beneficial ownership and 31,449 shares owned
by  RAS  Securities Corp.,  a registered broker-dealer, acquired in its ordinary
course  of  business  and  over which Mr. Schneider has voting  and  dispositive
power.

<PAGE>


                     ELECTION OF DIRECTORS

      Eight  directors are to be elected at the Meeting to serve until the  next
annual  meeting  of  the  Company's  stockholders  and  until  their  respective
successors  shall  have  been elected and shall have qualified  or  until  their
earlier resignation, removal from office or death.

Nominees

      The  following  table sets forth as of the Record Date, for  each  of  the
following  nominees for director, such person's age, position with  the  Company
and length of service as Director:


       Name and Age             Position with the Company  Director Since

Martin D. Sass (54)*       Chairman of the Board, Chief Executive
                           Officer and Director                      1994
Hugh R. Lamle (51)*        Executive Vice President and Director     1994
James B. Rubin (43)*       Senior Vice President and Director        1994
Thomas M. Garvin (61)      Director                                  1994
Lawrence W. Leighton (62)  Director                                  1994
Edward Lowenthal (51)      Director                                  1994
Daniel R. Mazziota (59)    Director                                  1994
Guy E. Waldvogel (60)      Director                                  1994


__________________

*    Director who is an "Interested Person" within the meaning of the Investment
Company Act of 1940 (the "1940 Act").

      The  following  is a detailed description of the profession  and  business
background of each director.

     MARTIN D. SASS is an executive officer and principal of M.D. Sass Investors
Services, Inc. (the "Investment Adviser"), the Company's investment adviser, and
various  affiliated  registered investment advisers  and  other  entities  which
comprise the M.D. Sass organization ("M.D. Sass"), founded by Mr. Sass in  1972.
Prior to founding M.D. Sass, Mr. Sass was President and principal shareholder of
Neuwirth  Management  and Research Corp. from 1969 to  1972,  where  he  managed
several  portfolios and mutual funds.  Mr. Sass was also a security  analyst  at
Argus  Research  Corp.  from 1963 to 1969, where he  founded  and  directed  the
Special Situations Department.  Mr. Sass holds a B.S. degree in Accounting  from
Brooklyn College, and has also studied finance in graduate programs in New  York
University and City College of New York.

      HUGH  R.  LAMLE is Executive Vice President and a principal of M.D.  Sass,
which  he joined in 1974.  Mr. Lamle is responsible for the formulation of fixed
income and quantitative investment policy and strategy, directing the management
at M.D. Sass of debt securities portfolios and directing the firm's new products
research  efforts.  Prior to joining M.D. Sass, Mr. Lamle in 1972 founded  Lenox
Capital Management, the investment management subsidiary of DuPont Glore Forgan,
Inc.   He  currently serves on the Board of the FINEX Division of the  New  York
Cotton  Exchange.   Mr.  Lamle  holds a B.A. degree  in  Political  Science  and
Economics  from  Queens College and an M.B.A. degree in Finance and  Investments
from Baruch College.

      JAMES B. RUBIN joined M.D. Sass as Senior Managing Director in 1989,  with
over  15 years experience in advising firms in reorganizations and other special
situations.   At  M.D.  Sass,  Mr.  Rubin is head  of  the  firm's  Restructured
Securities Management Division.  Mr. Rubin also serves as a director  of  Seaman
Furniture  Company,  Inc.  and  Chairman of the Board  of  Directors  of  Ranger
Industries,  Inc.   From 1986 until joining M.D. Sass, he was the  principal  of
J.B.  Rubin  and  Company.  From 1985 to 1986, Mr. Rubin was a Senior  Financial
Analyst  with  Smith  Vasiliou  and  its affiliates,  including  the  distressed
securities brokerage firm of R.D. Smith & Company, Inc.  Mr. Rubin is a graduate
of  Cornell  University, with an undergraduate degree in Industrial Engineering.
He  also participated in graduate M.B.A. studies in Finance at Cornell and  Pace
Universities.

      THOMAS  M. GARVIN has been Chairman and Chief Executive Officer of Edwards
Baking  Company,  a  concern  engaged  in leveraged  acquisitions  in  the  food
industry,  since  1994.  Prior thereto, Mr. Garvin served in  various  executive
capacities at Keebler Company, the second largest U.S. manufacturer and marketer
of  cookies  and crackers, from 1969 to 1993, including those of  President  and
Chief Executive Officer from 1978 to 1993 and Chief Operating Officer from  1976
to  1978.  During his tenure at Keebler Company, the company progressed  from  a
single  product  biscuit company to its current position of  prominence  in  the
baking  and  snack  industries.  Mr. Garvin holds B.S. and M.B.A.  degrees  from
Loyola University and is a certified public accountant.

     LAWRENCE W. LEIGHTON has been managing partner of Windward Partners LLC, an
investment  banking  firm  since February 1996.  Mr.  Leighton  was  a  Managing
Director of L.M. Capital, an investment banking and buy-out firm, from September
1994  to  January  1996.  From January 1989 to January 1994,  Mr.  Leighton  was
President and Chief Executive Officer of UI USA, the United States merchant bank
of  Credit Agricole, a large French-based bank.  From 1982 until joining UI USA,
Mr. Ixighton was Managing Director responsible for the international mergers and
acquisitions  activity  of Chase Investment Bank.  From  1977  until  1982,  Mr.
Leighton  was  a limited partner in the mergers and acquisitions  department  of
Bear,  Steams  &  Co.  and from 1974 until 1977, he was  Director  of  Strategic
Planning  of  Norton  Simon,  Inc.  Mr. Leighton  is  a  graduate  of  Princeton
University  with a B.S.E. degree in Engineering and holds an M.B.A. degree  from
Harvard Business School.

      EDWARD  LOWENTHAL is a founder, and since 1992 has served as  trustee  and
President,  of  Wellsford Residential Property Trust ("WRP"), a New  York  Stock
Exchange  listed  real estate investment trust.  In 1992, WRP succeeded  to  the
business   of  Wellsford  Group,  Inc.'s  (the  "Wellsford  Group")  multifamily
affiliates,  which  had  acquired and operated  multifamily  properties  in  the
Southwestern  and  Northwestern states since 1988.  Mr. Lowenthal  serves  as  a
director  of  United American Energy Corporation, a major developer,  owner  and
operator of hydroelectric and other alternative energy facilities; a director of
Omega  Healthcare, Inc., a healthcare real estate investment  trust;  and  as  a
trustee  of  Corporate  Realty  Income Trust, a  real  estate  investment  trust
sponsored by Smith Barney Shearson Inc.  Mr. Lowenthal is a member of the  Board
of  Governors  of  the  National Association of Real Estate  Investment  Trusts.
Prior  to Wellsford Group's formation, Mr. Lowenthal was engaged in the practice
of  law  for  15  years,  and was a partner of the New York  City  law  firm  of
Robinson, Silverman, Pearce, Aronsohn & Berman from 1981 to 1984.  In  1984  Mr.
Lowenthal  entered  investment banking as a Managing  Director  of  A.G.  Becker
Paribas  and  then  as a partner of Bear Stearns & Co. Inc.   As  an  investment
banker,  he  was active in structuring and negotiating transactions and  raising
the  equity  in  a  number of large real estate equity private placements.   Mr.
Lowenthal  holds a B.A. degree from Case Western Reserve University and  a  J.D.
degree from Georgetown University Law Center.

      DANIEL R. MAZZIOTA is principal of RSA Executive Search ("RSA"), which was
founded  in  1978.   RSA  specializes  in  recruitment  of  key  executives  and
management  personnel  in  the  consumer  goods  and  services,  healthcare  and
pharmaceutical,  finance,  electronics and  telecommunications  industries.   In
1967, Mr. Mazziota founded Microwave Power Devices, Inc. ("MPD"), which was sold
to  M/A-Com,  Inc. in 1981.  Mr. Mazziota continued as President  of  MPD  until
1987, when he became Chairman of RSA.  Mr. Mazziota also serves as President  of
IDM  Consulting,  which  provides business consulting  in  the  high  technology
mergers  and  acquisitions  field.  Mr. Mazziota  holds  Bachelors  and  Masters
degrees in Electrical Engineering from New York Polytechnic Institute.

      GUY  E. WALDVOGEL has been an independent consultant specializing  in  the
management of troubled companies in Europe since September 1989.  From  1983  to
1989,  he  was  the  Senior  Executive Vice President  of  Societe  Generale  de
Surveillance,  which provides services to foreign governments in  ensuring  that
imports and exports comply with weight, safety and engineering standards.   From
1981  to 1983, Mr. Waldvogel served as President and Chief Executive Officer  of
North American Holding of Alusuisse-Lonza Aluminum and Chemicals Group.  He  was
President  and  Chief  Executive Officer of Givaudan, a subsidiary  of  Hoffman-
LaRoche, from 1973 to 1981, and held other positions within Hoffman-LaRoche from
1965 until 1973.


Meetings of the Board of Directors

      During the fiscal year ended September 30, 1996, the Board of Directors of
the  Company held four meetings.  All directors were present at all meetings  of
the  Board  of Directors held during the fiscal year ended September  30,  1996,
except  for Messrs. Lamle and Rubin, who were unable to attend two meetings  and
Mr. Garvin, who was unable to attend one meeting.


Indemnification of Directors and Officers

      As  permitted  by Delaware law, the Company's Certificate of Incorporation
contains  an  article  limiting  the  personal  liability  of  directors.    The
Certificate of Incorporation provides that a director of the Company  shall  not
be  personally liable for monetary damages for a breach of fiduciary duty  as  a
director,  except  for liability (i) for any breach of the  director's  duty  of
loyalty,  (ii)  for  acts  or  omissions not in  good  faith  or  which  involve
intentional misconduct or a knowing violation of law, (iii) under Section 174 of
the  General  Corporation  Law  of the State of Delaware,  which  prohibits  the
unlawful payment of dividends or the repurchase or redemption of stock, or  (iv)
for  any  transaction  from  which the director  derived  an  improper  personal
benefit.   The  Company's Certificate of Incorporation also  provides  that  the
Company will indemnify all persons (including officers, directors and employees)
whom  it is empowered to indemnify pursuant to the provisions of Section 145  of
the Delaware General Corporation Law (or any similar provision of applicable law
at  the  time  in effect) to the full extent permitted thereby.   The  foregoing
provisions  are  subject,  however, to Section  17(h)  of  the  1940  Act  which
provides, in part, that neither the Certificate of Incorporation nor the by-laws
of  any  business  development company (such as the  Company)  shall  contain  a
provision which protects or purports to protect any officer or director of  such
business  development  company against any liability  to  such  company  or  its
security  holders  to which be would otherwise be subject  due  to  his  willful
misfeasance,  bad faith, gross negligence or reckless disregard  of  the  duties
involved  in  the conduct of his office.  The Company currently  maintains  $5.0
million of officer and director liability insurance.


Compliance with Section 16(a) of the Securities Exchange Act of 1934

      Section 16(a) of the Securities Exchange Act of 1934, as amended, requires
the Company's executive officers, directors and holders of more than ten percent
of  the  Company's  Common Stock, to file reports of ownership  and  changes  in
ownership with the Securities and Exchange Commission and Nasdaq.  Such  persons
are  required to furnish the Company with copies of all Section 16(a) forms they
file.   During the fiscal year ended September 30, 1995, all filing requirements
applicable  to  its officers, directors and greater than ten percent  beneficial
owners were complied with.

      The  Board  of  Directors recommends a vote "FOR"  each  of  the  proposed
nominees for the Board of Directors.

<PAGE>


                     EXECUTIVE COMPENSATION

Compensation of Executive Officers and Directors

      No  cash  compensation was paid by the Company to  any  of  its  executive
officers  during  the fiscal year ended September 30, 1996 and the  period  from
November 1, 1994 (commencement of operations) to September 30, 1995.  It is  not
anticipated that executive officers will receive direct cash compensation in the
foreseeable future.

     Each director who is not an executive officer of the Company is compensated
for  his  services  at  a  fee  of $10,000 per annum.   Each  director  is  also
reimbursed for travel and other out-of-pocket disbursements actually incurred in
the business of the Company.

     Executive officers and directors of the Company are permitted to retain any
compensation  received for services to other companies, including  companies  in
which the Company invests and to which it renders managerial assistance.


Financial Advisory Agreement and Fees

     The Investment Adviser

       The  Company  has  retained  M.D.  Sass  Investors  Services,  Inc.  (the
"Investment   Adviser")  as  the  Company's  investment  adviser  to   identify,
negotiate,  manage  and  liquidate investments for  the  Company.   The  Company
invests only in transactions recommended by the Investment Adviser.

      The  Investment  Adviser  is  a registered investment  adviser  under  the
Investment Advisers Act of 1940, as amended.  The Investment Adviser is part  of
a  group  of  affiliated  investment  advisers  and  other  affiliated  entities
comprising the M.D. Sass organization ("M.D. Sass").  Founded in 1972, M.D. Sass
is  engaged  in  investment management for in excess of 100  clients,  including
pension  and profit sharing funds, municipal employee benefits funds,  insurance
companies,  endowment  and  charitable funds,  large  corporations  and  wealthy
individuals.  M.D. Sass currently has approximately $8.0 billion in assets under
management.

      The  Investment  Adviser and certain other M.D. Sass affiliates  currently
serve   as   general  partners  of  M.D.  Sass  Re/Enterprise   Partners,   L.P.
("Re/Enterprise  Partners") and M.D. Sass Re/Enterprise-II L.P. ("Re/Enterprise-
II"),  private limited partnerships which have investment objectives similar  to
that  of the Company, achieving long-term capital appreciation of its assets  by
investing primarily in securities of companies that are experiencing significant
financial or business difficulties.

      Re/Enterprise  Partners, formed in October 1989, had approximately  $167.0
million  in  assets  as  of  September 30, 1996.   Re/Enterprise-II,  formed  in
February  1996,  had approximately $24 million in assets as of  the  same  date.
Re/Enterprise  Partners  was a member of a group which  acquired  a  controlling
interest  in  Seaman Furniture Company, Inc., a furniture retailer headquartered
in the New York City area, and Re/Enterprise Partners assisted such company in a
financial  restructuring.   Re/Enterprise  Partners  also  participated  in  the
financial  restructurings  of other companies, including  Memorex  Telex  Corp.,
Emerson  Radio Corp., Ranger Industries, Inc. (formerly known as Coleco,  Inc.),
SPI Holding, Inc., Leaseway Transportation Corp. and Forstmann & Company, Inc.

      In  addition to the two Re/Enterprise partnerships, the Investment Adviser
and/or  other  affiliates  of  M.D. Sass serve as general  partners  of  a  more
aggressive,  higher-risk private limited partnership that invests in financially
troubled  companies,  and  other private limited  partnerships  that  invest  in
municipal  and government securities and distressed real estate that appears  to
have  a  potential for recovery, and as investment adviser to a private offshore
investment  company pursuing investment strategies similar to the  Re/Enterprise
partnerships and the Company, as well as a corporate pension fund of  a  Fortune
100 company.

      The principals of the Investment Adviser and other affiliates of M.D. Sass
are  Martin  D.  Sass and Hugh R. Lamle, each of whom serves as an  officer  and
director of the Company.  James B. Rubin and Martin E. Winter, officers  of  the
Investment Adviser and other affiliates of M.D. Sass, serve as officers  of  the
Company.  In addition, Mr. Rubin also serves as a director of the Company.

      The  offices of the Investment Adviser are located at 1185 Avenue  of  the
Americas,  18th  Floor, New York, New York  10036, and its telephone  number  is
(212) 730-2000.


     The Financial Advisory Agreement

      The Company is party to a Financial Advisory Agreement with the Investment
Adviser  (the "Financial Advisory Agreement").  The Investment Adviser's  duties
under the Financial Advisory Agreement include locating, structuring, acquiring,
monitoring and disposing of investments for the Company.  The Company only makes
investments recommended by the Investment Adviser.  In addition, the  Investment
Adviser  also  provides  administrative services to the Company,  including  all
necessary  executive, administrative, internal accounting and  support  services
and  furnishes the Company with necessary office space.  The activities  of  the
Investment  Adviser on behalf of the Company are subject to the  supervision  of
the independent Directors of the Company.

      Pursuant  to  the  Financial Advisory Agreement,  the  Investment  Adviser
receives  a base fee of $200,000 per annum for furnishing the Company  with  the
administrative services described above.

      In  addition to the base fee, the Investment Adviser receives an incentive
fee  for  its investment advisory services equal to 20% of net new appreciation,
if  any,  in  the  net  asset value of the shares of Common  Stock  outstanding,
adjusted  for all operating expenses, including accruals for any tax liabilities
on  income  or  gains  from portfolio transactions.  The initial  incentive  fee
calculation was made in November 1995, when the shares of Common Stock issued in
the Company's November 1994 initial public offering and contemporaneous offshore
private placement were outstanding for at least one year.  A new calculation has
been  and  will  continue  to  be  made at the  end  of  each  calendar  quarter
thereafter,  with  the  Investment  Adviser  receiving  20%  of  any   net   new
appreciation occurring during the preceding four calendar quarters.   Thus,  the
fee is computed and paid on a "rolling quarter" basis.

      At  any time the incentive fee is to be calculated, if the net asset value
per  share previously has reached a level at which an incentive fee was paid  (a
"previous  high  peak"), an additional incentive fee will be paid  only  on  the
incremental  appreciation of the shares of Common Stock  over  the  shares'  net
asset  value  after payment of the previous incentive fee at such peak.   In  no
event will an incentive fee be paid for recoupment of losses.  Thus, if the  net
asset  value  of  the shares of Common Stock falls below the initial  net  asset
value,  or the previous high peak at which the incentive fee was paid (less  the
incentive  fee paid at such level), no incentive fee will be due the  Investment
Adviser.   The  Investment Adviser will only be entitled to a further  incentive
fee  if the net asset value of the shares increases beyond the initial net asset
value,  or  its net asset value following payment of the incentive  fee  at  the
previous  high  peak,  as  the  case  may be.   Notwithstanding  the  foregoing,
incentive  fees  payable to the Investment Adviser under the Financial  Advisory
Agreement  will  not exceed the maximum amount which the Investment  Adviser  is
entitled  to receive under the 1940 Act.  During the fiscal year ended September
30,  1996, and the period from November 1, 1994 (commencement of operations)  to
September  30, 1995, the Company accrued fees payable to the Investment  Adviser
of  $224,128 and $996,947, respectively, under the Financial Advisory Agreement.
Since  September 30, 1996, no incentive fee has been accrued since the Company's
net asset value has been below the previous high peak.

     The Investment Adviser bears the expense of maintaining the staff necessary
for  performing its obligations under the Financial Advisory Agreement  and  all
other  expenses  associated with its duties as Investment Adviser.   Other  than
fees  payable  under  the  Financial Advisory Agreement and  Investment  Banking
Agreement,  the Company bears no operating expenses other than normal  operating
expenses such as legal and auditing fees, taxes and all direct expenses  related
to an investment including all investment, legal and accounting expenses.

      The Financial Advisory Agreement had an initial term of two years (through
October  30, 1996) and thereafter continues from year to year if approved  by  a
majority  of  independent  directors and unless not less  than  30  days'  prior
written  notice  is  given  by  a party of its  intention  not  to  renew.   The
independent  directors of the Company unanimously approved the  renewal  of  the
Financial  Advisory Agreement for a one-year period through October  1997.   The
Financial  Advisory Agreement is not assignable and may be terminated by  either
party upon 60 days prior written notice given to the other party.


Compensation Committee Interlocks and Insider Participation

     The Board of Directors does not have a Compensation Committee and decisions
as  to  compensation  are  made  by the Board of  Directors  as  a  whole.   See
"Financial  Advisory  Agreement and Fees - The Investment  Adviser"  above  with
respect to relationships between certain of the Company's executive officers and
directors and the Investment Adviser.


Report on Executive Compensation

     The following report is submitted by the Board of Directors, the membership
of which is set forth below the report:

      There  is  no  Compensation Committee of the Board of Directors  or  other
committee  of the Board performing equivalent functions.  Compensation decisions
are made by the Board of Directors as a whole.  No cash compensation was paid by
the  Company  to  any  of its executive officers during the  fiscal  year  ended
September  30,  1996  and  it is not anticipated that  executive  officers  will
receive  direct cash compensation in the foreseeable future.  Executive officers
of the Company are permitted to retain any compensation received for services to
other  companies, including companies in which the Company invests and to  which
it renders managerial assistance.

                        Martin D. Sass
                        Hugh R. Lamle
                        James B. Rubin
                        Thomas M. Garvin
                        Lawrence W. Leighton
                        Edward Lowenthal
                        Daniel R. Mazziota
                        Guy E. Waldvogel



Stock Performance Graph

     The following line graph compares, from October 25, 1994, the first day  on
which  the  Company's  Common Stock was publicly traded, through  September  30,
1996,  the  cumulative total return among the Company, companies comprising  the
Nasdaq  Market  Index and to the Media General Group Index of  closed-end  funds
(the  "MG Group Index"), based on an investment of $100 on October 25,  1994  in
the  Company's  Common Stock and each index, and assuming  reinvestment  of  all
dividends,  if  any,  paid  on such securities.  Historic  stock  price  is  not
necessarily indicative of future stock price performance.













                      COMPARISON OF CUMULATIVE TOTAL RETURN
                       CORPORATE RENAISSANCE GROUP, INC.,
                     NASDAQ MARKET INDEX AND MG GROUP INDEX

                                                          September 30,
                                  October 25, 1994      1995         1996

Corporate Renaissance Group, Inc.  $      100.00  $     93.90    $    78.00

Nasdaq Market Index                $      100.00  $     111.89   $    124.28

MG Group Index                     $      100.00  $     120.30   $    140.45

Certain Relationships and Related Transactions

      See  "Financial Advisory Agreement and Fees" with respect to the Financial
Advisory Agreement entered into with the Investment Adviser.

      The  Company  invests  from time to time jointly with  affiliates  of  the
Investment Adviser subject to restrictions under the 1940 Act and conditions set
forth in an exemptive order granted by the SEC.

     The Company from time to time also effects securities sales to or purchases
from  affiliates  of  the  Investment Adviser pursuant  to  a  plan  adopted  in
accordance with Rule 17a-7 under the 1940 Act.


       RATIFICATION OF SELECTION OF INDEPENDENT AUDITORS

      Unless instructed to the contrary, the persons named in the enclosed proxy
intend to vote the same in favor of the ratification of the selection of Ernst &
Young  LLP  as  independent auditors to the Company for the fiscal  year  ending
September 30, 1997.

      On  December 15, 1994, the Company terminated Feldman Radin  &  Co.,  P.C.
("FRC")  as  its independent auditors.  FRC had audited the Company's  financial
statements  for all periods prior to September 30, 1994.  FRC's reports  on  the
Company's  financial  statements  neither  contained  any  adverse  opinions  or
disclaimers  of opinions nor were qualified or modified as to uncertainty.   The
decision  to  terminate its relationship with FRC was approved by the  Board  of
Directors of the Company.  There were no disagreements with FRC on any matter of
accounting  principles or practices, financial statement disclosure or  auditing
scope or procedure, which disagreements, if not resolved to the. satisfaction of
FRC,  would  have  caused  it to make reference to the  subject  matter  of  the
disagreements in connection with its reports.

      Pursuant  to  action  approved by the Company's Board  of  Directors,  the
Company retained Ernst & Young LLP as its auditors as of December 15, 1994.

     It is anticipated that representatives of Ernst & Young LLP will attend the
meeting.   Such  persons will be afforded the opportunity to  make  a  statement
and/or respond to appropriate questions from stockholders.

      The  Board  of  Directors  recommends a vote  "FOR"  ratification  of  the
selection  of Ernst & Young LLP as independent auditors to the Company  for  the
fiscal year ending September 30, 1997.


                              STOCKHOLDER PROPOSALS

     Stockholder proposals intended to be presented at the Company's 1998 Annual
Meeting  of  Stockholders  pursuant to the  provisions  of  Rule  14a-8  of  the
Securities  and  Exchange Commission, promulgated under the Securities  Exchange
Act  of  1934,  as  amended, must be received by the Company  at  its  principal
executive  offices  by September 24, 1997 for inclusion in the  Company's  proxy
statement and form of proxy relating to such meeting.


                                    MARTIN E. WINTER,
                                    Secretary
New York, New York
January 22, 1997


THE  COMPANY  WILL FURNISH WITHOUT CHARGE TO EACH PERSON WHOSE  PROXY  IS  BEING
SOLICITED, UPON THE WRITTEN REQUEST OF ANY SUCH PERSON, A COPY OF THE  COMPANY'S
ANNUAL  REPORT  ON FORM 10-K FOR THE FISCAL YEAR ENDED SEPTEMBER  30,  1996,  AS
FILED  WITH  THE  SECURITIES AND EXCHANGE COMMISSION,  INCLUDING  THE  FINANCIAL
STATEMENTS  THERETO.  REQUESTS FOR COPIES OF SUCH REPORT SHOULD BE  DIRECTED  TO
SECRETARY, CORPORATE RENAISSANCE GROUP, INC., 1185 AVENUE OF THE AMERICAS,  18TH
FLOOR, NEW YORK, NEW YORK  10036.


<PAGE>
COMMON STOCK PROXYCORPORATE RENAISSANCE GROUP, INC.
            1185 Avenue of the Americas, 18th Floor
                   New York, New York  10036

  THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS

     The  undersigned holder of shares of Common Stock of CORPORATE  RENAISSANCE
GROUP,  INC., a Delaware corporation (the "Company"), hereby appoints MARTIN  D.
SASS  and MARTIN E. WINTER, and each or either of them, the proxy or proxies  of
the  undersigned, with full power of substitution to such proxy and  substitute,
to  vote  all  shares  of Common Stock of the Company which the  undersigned  is
entitled to vote at the Annual Meeting of Stockholders of the Company to be held
at  9:30  A.M.,  local time, February 19, 1997, and at all adjournments  thereof
with authority to vote said Common Stock on the matters set forth below:

     The  shares of Common Stock represented by this Proxy will be voted in  the
manner directed herein by the undersigned stockholder, who shall be entitled  to
one  vote  for each share of Common Stock held.  If no direction is  made,  this
Proxy will be voted FOR each item listed below.

  The Board of Directors recommends a vote FOR each proposal.

     B.    ELECTION  OF DIRECTORS.  Election of Martin D. Sass, Hugh  R.  Lamle,
James B. Rubin, Thomas M. Garvin, Lawrence W. Leighton, Edward Lowenthal, Daniel
R. Mazziota and Guy E. Waldvogel.

         __  FOR each nominee listed above (except as noted below).
         __  WITHHOLD AUTHORITY to vote for all nominees listed above.
         __  WITHHOLD AUTHORITY for each nominee printed below:

              ___________________________________________
              (please print)

     C.    Ratify  the  appointment  of Ernst  &  Young  LLP  as  the  Company's
independent auditors for the fiscal year ending September 30, 1997.

              __  FOR   __  AGAINST   __  ABSTAIN

     D.    In  their  discretion, upon such other business as  may  be  properly
brought before the meeting and each adjournment thereof.


                  (continued on reverse side)

<PAGE>
                  (continued from other side)


               CORPORATE RENAISSANCE GROUP, INC.

THIS  PROXY WILL BE VOTED AS SPECIFIED; IF NO SPECIFICATION IS MADE, THIS  PROXY
WILL BE VOTED FOR EACH OF THE MATTERS MENTIONED.


                                   Dated:


                                   (Signature)



                                   (Signature)

                                   PLEASE  SIGN YOUR NAME EXACTLY AS IT  APPEARS
                                   ON  THE  LEFT.    EXECUTORS,  ADMINISTRATORS,
                                   TRUSTEES,  GUARDIANS,  ATTORNEYS  AND  AGENTS
                                   SHOULD  GIVE  THEIR  FULL TITLES  AND  SUBMIT
                                   EVIDENCE  OF  APPOINTMENT  UNLESS  PREVIOUSLY
                                   FURNISHED  TO  THE COMPANY  OR  ITS  TRANSFER
                                   AGENT.  ALL JOINT OWNERS SHOULD SIGN.

                                   PLEASE MARK, DATE, SIGN AND RETURN USING  THE
                                   ENCLOSED  ENVELOPE.   YOUR  PROMPT  ATTENTION
                                   WILL BE APPRECIATED



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission